Lupin 2023

Video Forum: Christine Baeder, Teva USA

Print Friendly, PDF & Email

New AAM chairwoman says generics industry is at a crossroads.

Christine Baeder, chief operating officer for generics and biosimilars at Teva USA and newly named chair of the Association for Accessible Medicines, tells this week’s Video Forum about the threats facing the generic pharmaceutical industry and what should be done to counter them. She also discusses the relatively slow pace of adoption of biosimilars in the U.S., the impact of innovative payment models on the marketplace, and the value that generics represent.




Comments are closed.